Literature DB >> 16139510

Cloning, purification, and refolding of human paraoxonase-3 expressed in Escherichia coli and its characterization.

Haiqin Lu1, Jie Zhu, Yuhui Zang, Yuguan Ze, Junchuan Qin.   

Abstract

Human paraoxonase (hPON3) is a high density lipoprotein-related glycoprotein with multi-enzymatic properties and antioxidant activity which is proposed to participate in the prevention of low density lipoprotein (LDL) oxidation. In this study, hPON3 gene was amplified from Human Fetal Liver Marathon-Ready cDNA and expressed in Escherichia coli. A majority of the expressed protein existed as inclusion bodies. The inclusion bodies were solubilized with Triton X-100 and refolded in vitro. The refolded rhPON3 was purified by DEAE-Sepharose Fast Flow and its purity was up to 90%. The Km and Vmax values of refolded rhPON3, in respect to phenylacetate hydrolysis were 7.47 +/- 2.14 mM and 66 +/- 17 U/min/mg (n = 3). The Km and Vmax values of refolded rhPON3, in respect to dihydrocoumarin hydrolysis were 0.83 +/- 0.21 mM and 621 +/- 66 U/min/mg (n = 3). The refolded rhPON3 exhibited similar antioxidant activity to that of rhPON3 purified from the soluble fraction of cell lysate and could effectively protect LDL from Cu2+ induced oxidation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139510     DOI: 10.1016/j.pep.2005.07.021

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

2.  FOXP2 targets show evidence of positive selection in European populations.

Authors:  Qasim Ayub; Bryndis Yngvadottir; Yuan Chen; Yali Xue; Min Hu; Sonja C Vernes; Simon E Fisher; Chris Tyler-Smith
Journal:  Am J Hum Genet       Date:  2013-04-18       Impact factor: 11.025

3.  Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis.

Authors:  Stephan Riedmaier; Kathrin Klein; Stefan Winter; Ute Hofmann; Matthias Schwab; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2011-07-27       Impact factor: 5.810

Review 4.  Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease.

Authors:  Kumari Priyanka; Surjit Singh; Kirandip Gill
Journal:  Biomolecules       Date:  2019-12-03

Review 5.  Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins.

Authors:  Athina Trakaki; Gunther Marsche
Journal:  Biomedicines       Date:  2021-05-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.